Second Sight Medical (NASDAQ: EYES) reported Q1 EPS of ($0.16), $0.02 worse than the analyst estimate of ($0.14). Revenue for the quarter came in at $1.01 million versus the consensus estimate of $1.32 million.

For earnings history and earnings-related data on Second Sight Medical (EYES) click here.